Study Stopped
Difficulty in recruiting subjects due to a variety of factors beyond our control.
Impact of Negative Pressure Ventilation in Patients Hospitalized With Acute Hypercapnic Respiratory Failure
1 other identifier
interventional
50
1 country
1
Brief Summary
The study aims to find if using a Biphasic Cuirass Ventilation is as effective as using a Non invasive Positive Pressure Ventilation in patients admitted with acute hypercapnic respiratory failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 9, 2023
CompletedFirst Posted
Study publicly available on registry
October 31, 2023
CompletedStudy Start
First participant enrolled
April 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 21, 2025
CompletedFebruary 13, 2026
February 1, 2026
1.2 years
October 9, 2023
February 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Resolution of Hypercapnic Respiratory Failure
Resolution of Hypercapnic Respiratory failure will be assessed and compared with the current standard of care which is non invasive positive pressure ventilation using Arterial or Venous Blood Gas analysis.
1-3 days
Study Arms (2)
Conventional Arm
NO INTERVENTIONPatients will be placed on Non invasive positive pressure ventilation per current standard of care.
Intervention Arm
ACTIVE COMPARATORPatient in this arm will be placed on Biphasic Cuirass Ventilation
Interventions
Patients in this arm will be placed on Biphasic cuirass ventilation
Eligibility Criteria
You may qualify if:
- admission diagnosis of hypercapnic respiratory failure
- pH between 7.20-7.35 in an ABG sample or pH between 7.16-.31 in a venous sample.
You may not qualify if:
- age \<21
- Pregnant
- Inmate/Prisoner
- Contraindication for cuirass ventilator (open chest wound, flail chest, prior thoracic surgery)
- Chest wall defect, neuromuscular disease or diaphragmatic paralysis.
- BMI \>50
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Missouri-Columbialead
- Hayek Medicalcollaborator
Study Sites (1)
University of Missouri Hospitals
Columbia, Missouri, 65212, United States
Related Publications (2)
Dolmage TE, De Rosie JA, Avendano MA, Goldstein RS. Effect of external chest wall oscillation on gas exchange in healthy subjects. Chest. 1995 Feb;107(2):433-9. doi: 10.1378/chest.107.2.433.
PMID: 7842774BACKGROUNDPlant PK, Owen JL, Elliott MW. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet. 2000 Jun 3;355(9219):1931-5. doi: 10.1016/s0140-6736(00)02323-0.
PMID: 10859037RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dennis Chairman, MD
University of Missouri-Columbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- can't be done as the two devices are completely different.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Clinical Medicine
Study Record Dates
First Submitted
October 9, 2023
First Posted
October 31, 2023
Study Start
April 3, 2024
Primary Completion
June 21, 2025
Study Completion
June 21, 2025
Last Updated
February 13, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
No plan to share individual participant data to anyone outside the study.